Cargando…

Invasive Aspergillosis in Patients Treated With Ibrutinib

Detalles Bibliográficos
Autores principales:	Fürstenau, Moritz, Simon, Florian, Cornely, Oliver A., Hicketier, Tillman, Eichhorst, Barbara, Hallek, Michael, Mellinghoff, Sibylle C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162080/ https://www.ncbi.nlm.nih.gov/pubmed/32309779 http://dx.doi.org/10.1097/HS9.0000000000000309

Ejemplares similares

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
por: Nyga, Rémy, et al.
Publicado: (2019)

Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
por: Fürstenau, Moritz, et al.
Publicado: (2019)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
por: von Tresckow, Julia, et al.
Publicado: (2022)

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?
por: Fürstenau, Moritz, et al.
Publicado: (2019)

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
por: Arthurs, Benjamin, et al.
Publicado: (2017)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

COVID-19 among fit patients with CLL treated with venetoclax-based combinations
por: Fürstenau, Moritz, et al.
Publicado: (2020)

Novel Agents in Chronic Lymphocytic Leukemia: New Combination Therapies and Strategies to Overcome Resistance
por: Fürstenau, Moritz, et al.
Publicado: (2021)

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

COVID‐19 associated pulmonary aspergillosis
por: Koehler, Philipp, et al.
Publicado: (2020)

Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2019)

Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia
por: Beresford, Rohan, et al.
Publicado: (2019)

COVID‐19 complicated by parainfluenza co‐infection in a patient with chronic lymphocytic leukemia
por: Langerbeins, Petra, et al.
Publicado: (2020)

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
por: Stemler, Jannik, et al.
Publicado: (2023)

Dexamethasone/ibrutinib/prednisolone: Invasive CNS aspergillosis due to Aspergillus fumigatus infection: 3 case reports
Publicado: (2021)

Systemic Aspergillosis: Radiological Findings in a Case With Diffuse Large B Cell Lymphoma Treated by Ibrutinib
por: Pehlivan, Umur Anil, et al.
Publicado: (2021)

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect
por: Schumacher, Sofie, et al.
Publicado: (2020)

Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
por: Cramer, Paula, et al.
Publicado: (2020)

The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation
por: Winiszewski, Hadrien, et al.
Publicado: (2018)

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED CLL12 TRIAL
por: Langerbeins, Petra, et al.
Publicado: (2023)

Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2018)

Metadata Correction: Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2019)

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
por: Thompson III, George R, et al.
Publicado: (2020)

Candida auris in Germany and Previous Exposure to Foreign Healthcare
por: Hamprecht, Axel, et al.
Publicado: (2019)

72/m mit Zufallsbefund einer Lymphozytose: Vorbereitung auf die Facharztprüfung: Fall 34
por: Langerbeins, Petra, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis in three cases of influenza
por: Selegatto, Glória, et al.
Publicado: (2022)

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
por: Montillo, M, et al.
Publicado: (2017)

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
por: Reda, Gianluigi, et al.
Publicado: (2018)

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab
por: Kreuzer, Karl-Anton, et al.
Publicado: (2019)

Invasive aspergillosis in patients with severe COVID-19 pneumonia
por: Helleberg, Marie, et al.
Publicado: (2021)

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
por: Blaize, Marion, et al.
Publicado: (2020)

Invasive Aspergillosis in Refractory Angioimmunoblastic T-Cell Lymphoma
por: NP, Prakash, et al.
Publicado: (2018)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: van der Linden, Jan W.M., et al.
Publicado: (2016)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_seilbot3cjno0qdouhtsa92fb0